Virpax Pharmaceuticals Stock Price Prediction

VRPX Stock  USD 3.77  0.11  2.84%   
At this time, the RSI of Virpax Pharmaceuticals' share price is approaching 47. This entails that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Virpax Pharmaceuticals, making its price go up or down.

Oversold Vs Overbought

47

 
Oversold
 
Overbought
Virpax Pharmaceuticals stock price prediction is an act of determining the future value of Virpax Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Virpax Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Virpax Pharmaceuticals and does not consider all of the tangible or intangible factors available from Virpax Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with Virpax Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Virpax Pharmaceuticals' stock price prediction:
EPS Estimate Current Year
(7.30)
EPS Estimate Next Year
(7.40)
Wall Street Target Price
20
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Virpax Pharmaceuticals based on different types of headlines from major news networks to social media. The Virpax stock price prediction module provides an analysis of price elasticity to changes in media outlook on Virpax Pharmaceuticals over a specific investment horizon. Using Virpax Pharmaceuticals hype-based prediction, you can estimate the value of Virpax Pharmaceuticals from the perspective of Virpax Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Virpax Pharmaceuticals. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Virpax Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Virpax because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Virpax Pharmaceuticals after-hype prediction price

    
  USD 3.76  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Virpax Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Virpax Stock please use our How to Invest in Virpax Pharmaceuticals guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Virpax Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.183.5911.17
Details
Naive
Forecast
LowNextHigh
0.073.2610.84
Details
1 Analysts
Consensus
LowTargetHigh
3.644.004.44
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-1.82-1.82-1.82
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Virpax Pharmaceuticals. Your research has to be compared to or analyzed against Virpax Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Virpax Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Virpax Pharmaceuticals.

Virpax Pharmaceuticals After-Hype Price Prediction Density Analysis

As far as predicting the price of Virpax Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Virpax Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Virpax Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Virpax Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Virpax Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Virpax Pharmaceuticals' historical news coverage. Virpax Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.19 and 11.34, respectively. We have considered Virpax Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
3.77
3.76
After-hype Price
11.34
Upside
Virpax Pharmaceuticals is very risky at this time. Analysis and calculation of next after-hype price of Virpax Pharmaceuticals is based on 3 months time horizon.

Virpax Pharmaceuticals Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Virpax Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Virpax Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Virpax Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.56 
7.58
  0.01 
  0.39 
5 Events / Month
6 Events / Month
In about 5 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
3.77
3.76
0.27 
75,800  
Notes

Virpax Pharmaceuticals Hype Timeline

Virpax Pharmaceuticals is at this time traded for 3.77. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of -0.39. Virpax is projected to decline in value after the next headline, with the price expected to drop to 3.76. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.27%, whereas the daily expected return is at this time at 0.56%. The volatility of related hype on Virpax Pharmaceuticals is about 1075.18%, with the expected price after the next announcement by competition of 3.38. About 49.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 0.7. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Virpax Pharmaceuticals recorded a loss per share of 11.7. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 1st of March 2024. Given the investment horizon of 90 days the next projected press release will be in about 5 days.
Check out Virpax Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Virpax Stock please use our How to Invest in Virpax Pharmaceuticals guide.

Virpax Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Virpax Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Virpax Pharmaceuticals' future price movements. Getting to know how Virpax Pharmaceuticals rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Virpax Pharmaceuticals may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
FLEXFlex 0.07 9 per month 1.42  0.13  4.35 (2.53) 12.28 
NTGRNETGEAR(0.69)9 per month 2.10 (0) 3.24 (2.94) 13.02 
SPHRSphere Entertainment Co 1.12 11 per month 1.78  0.15  6.15 (2.90) 14.51 
JBLJabil Circuit(3.96)9 per month 3.29 (0.01) 2.64 (2.13) 21.31 
TVGrupo Televisa SAB 0.07 7 per month 0.00 (0.07) 4.56 (4.11) 21.27 
REREATRenew Inc DRC(0.05)5 per month 0.00 (0.03) 5.66 (7.22) 34.11 
ZDZiff Davis(2.37)10 per month 0.00 (0.12) 2.22 (3.20) 8.79 
ASURAsure Software 0.17 7 per month 0.00 (0.09) 3.92 (5.04) 19.58 

Virpax Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Virpax price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Virpax using various technical indicators. When you analyze Virpax charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Virpax Pharmaceuticals Predictive Indicators

The successful prediction of Virpax Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Virpax Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Virpax Pharmaceuticals based on analysis of Virpax Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Virpax Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Virpax Pharmaceuticals's related companies.

Story Coverage note for Virpax Pharmaceuticals

The number of cover stories for Virpax Pharmaceuticals depends on current market conditions and Virpax Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Virpax Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Virpax Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Virpax Pharmaceuticals Short Properties

Virpax Pharmaceuticals' future price predictability will typically decrease when Virpax Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Virpax Pharmaceuticals often depends not only on the future outlook of the potential Virpax Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Virpax Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding1.2 B
Cash And Short Term Investments9.1 B
When determining whether Virpax Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Virpax Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Virpax Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Virpax Pharmaceuticals Stock:
Check out Virpax Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Virpax Stock please use our How to Invest in Virpax Pharmaceuticals guide.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Virpax Stock analysis

When running Virpax Pharmaceuticals' price analysis, check to measure Virpax Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virpax Pharmaceuticals is operating at the current time. Most of Virpax Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Virpax Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virpax Pharmaceuticals' price. Additionally, you may evaluate how the addition of Virpax Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
CEOs Directory
Screen CEOs from public companies around the world
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Is Virpax Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Virpax Pharmaceuticals. If investors know Virpax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Virpax Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(11.70)
Return On Assets
(0.50)
Return On Equity
(1.05)
The market value of Virpax Pharmaceuticals is measured differently than its book value, which is the value of Virpax that is recorded on the company's balance sheet. Investors also form their own opinion of Virpax Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Virpax Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Virpax Pharmaceuticals' market value can be influenced by many factors that don't directly affect Virpax Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Virpax Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Virpax Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Virpax Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.